Clinical Trial Update: Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on using spironolactone to prevent ischemic kidney injury in critically ill cancer patients, with Phase 2 and Phase 3 studies ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Kidney Injury

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Critically Ill, Cancer | Phase 2, Phase 3 | Status: UNKNOWN